Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: Hashicorp - You Need To See This

Big Blue’s Big Bet: IBM Buys AI Nervous System for $11B

IBM's strategic acquisition of Confluent is a major investment to secure the foundational real-time data infrastructure needed for the future of enterprise AI.

Is IBM’s AI Transformation Powering a Sustained Rally?

Is IBM’s AI Transformation Powering a Sustained Rally?

IBM's stock rally reflects market validation of its enterprise AI strategy, key acquisitions, and growing bullish sentiment from influential analysts.

IBM Is Launching a New Quantum Computer. Should You Buy Its Stock Here?

IBM Is Launching a New Quantum Computer. Should You Buy Its Stock Here?

IBM’s announcement of its plans to develop the world’s first large-scale fault-tolerant quantum computer, Quantum Starling, has sparked excitement.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

IBM's AI Offensive: Assessing IBM's Path to Renewed Growth

IBM's enterprise-focused AI strategy, leveraging watsonx and agent capabilities, aims to drive significant growth, building upon its foundational stability.

Can IBM’s Q1 Earnings Spark a Breakout for the Stock?

IBM leverages its established foundation and strategic shift towards hybrid cloud and AI, presenting a potentially undervalued opportunity for tech investors.

Big Blue's Big Shift: IBM's Turnaround Bet on Cloud and AI

IBM's focus on hybrid cloud and AI shows progress as strategic shifts and improved financials signal a potential resurgence for the technology giant.

Hidden Gems: Uncovering 2024's Best Software Stocks

Beyond the tech titans, hidden software development gems are quietly delivering impressive returns and shaping the future of the software sector.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is International Business Machines Stock Underperforming the Nasdaq?

Is International Business Machines Stock Underperforming the Nasdaq?

International Business Machines has recently lagged the Nasdaq Composite, and analysts remain cautious about the stock’s prospects.

IBM Has a Healthy 4% Dividend Yield, But Is the Stock a Buy?

IBM Has a Healthy 4% Dividend Yield, But Is the Stock a Buy?

IBM has a dividend yield of nearly 4%, and has been aggressively working on expanding its AI offerings. However, the stock does not look like a compelling buy, despite having corrected from its 2024 highs.

IBM acquires HashiCorp in multi-billion dollar deal to boost cloud reach

IBM acquires HashiCorp in multi-billion dollar deal to boost cloud reach

HashiCorp agrees to $6.4 billion takeover deal by IBM as the companies look to take on more of the market.

IBM Acquires Hashicorp For .4 Billion To Boost Cloud Presence

IBM Acquires Hashicorp For .4 Billion To Boost Cloud Presence

IBM's .4 billion acquisition of HashiCorp to strengthen cloud offerings and drive innovation in the industry.

12 Information Technology Stocks Moving In Wednesday's Intraday Session

12 Information Technology Stocks Moving In Wednesday's Intraday Session

Is HashiCorp a Buy Under $35?

Is HashiCorp a Buy Under $35?

HashiCorp (HCP) shares have plummeted significantly in price since their market debut and are currently trading under $35. While the company has witnessed solid growth in terms of customer acquisition in the latest quarterly release, its lack of profitability is concerning. So, is it worth buying the stock now? Let’s…

10 Analysts Have This to Say About HashiCorp

10 Analysts Have This to Say About HashiCorp

Over the past 3 months, 10 analysts have published their opinion on HashiCorp (NASDAQ:HCP) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Get all your
news in one place.

100's of premium titles.
One news app.

Where HashiCorp Stands With Analysts

Within the last quarter, HashiCorp (NASDAQ:HCP) has observed the following analyst ratings:

Insiders Buy Around $63M Of 2 Stocks

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.

Executives Buy Around $413M Of 3 Stocks

Although Dow Jones dropped around 800 points on Tuesday, there were a few notable insider trades.

Where HashiCorp Stands With Analysts

Analysts have provided the following ratings for HashiCorp (NASDAQ:HCP) within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Expert Ratings For HashiCorp

HashiCorp (NASDAQ:HCP) has observed the following analyst ratings within the last quarter:

HashiCorp: Down 60% YTD, Still Too Expensive

IPO unicorn HashiCorp (HCP) is down more than 60% year-to-date, and its losses widened in the fourth quarter. So, let’s find out if it is wise to bet on the stock now.

1

Organisations

Palo Alto Networks

Manhattan Associates

Sensient Technologies

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

385,510 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play